Technology
Health
Pharmaceutical

BauschHealth

$24.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (0.33%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell BauschHealth and other stocks, options, ETFs, and crypto commission-free!

About

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. Read More The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Employees
21,100
Headquarters
Laval, Québec
Founded
1994
Market Cap
8.45B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
5.65M
High Today
$24.68
Low Today
$24.10
Open Price
$24.30
Volume
756.68K
52 Week High
$28.45
52 Week Low
$14.96

Collections

Technology
Health
Pharmaceutical
Medical
Medical Devices
Canada
North America

News

BenzingaMar 18

Bullish Mizuho Says Bausch Health's Long-Term Guidance 'Within Reach' (NYSE:BHC)

Bausch Health Companies Inc’s (NYSE: BHC) growth drivers will become “more tangible” in 2019, and shares could appreciate as the company continues to demonstrate good execution, according to Mizuho Securities.

120
Seeking AlphaMar 12

Bausch Health Care: A Dog Or A Diamond In The Rough?

Identifying and weighing the pros and cons of the company - as the former $270/share stock tries to pay down debt, and make more recent $8/share lows simply memories of the past.

284
Guru FocusFeb 28

Bausch Health Companies Inc (BHC) CHAIRMAN & CEO Joseph C Papa Bought $710,100 of Shares

CHAIRMAN & CEO of Bausch Health Companies Inc (NYSE:BHC) Joseph C Papa bought 30,000 shares of BHC on 02/28/2019 at an average price of $23.67 a share.

1,592

Earnings

$0.00
$0.38
$0.77
$1.15
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.